Role of 18F-FDG PET/CT in the diagnosis and treatment response assessment of primary pulmonary lymphoma
The various pathological types of PPLs differ in their metabolic characteristics. PPL has a good prognosis but is not sensitive to treatment. PET/CT is integral in the diagnosis, staging, and evaluation of treatment efficacy in PPL and should be considered in clinical decision-making.
Authors
- Hairong He (ORCID: https://orcid.org/0000-0002-6988-6423)
- Zhiyong Deng (ORCID: https://orcid.org/0000-0001-9761-9720)
- Ran Xie (ORCID: https://orcid.org/0000-0002-0250-323X)
- Yuqiang Xiao
- Yongzhu Pu
- Qiuyuan Hu
- Long Chen (ORCID: https://orcid.org/0000-0003-1333-0132)
- Sheng Zhao (ORCID: https://orcid.org/0000-0002-1030-5284)
- Xin Liu (ORCID: https://orcid.org/0000-0002-4611-9790)
- Kun Li (ORCID: https://orcid.org/0000-0001-6550-4937)
- Ningning Chen (ORCID: https://orcid.org/0000-0002-4795-9046)
- Chunhong Zhang (ORCID: https://orcid.org/0000-0002-1210-622X)
Institutions
- Peking University (CN)
- Kunming Medical University (CN)
- Peking University Cancer Hospital (CN)
Publication Details
- Journal
- Translational Cancer Research
- Published
- 2025-10-01
- DOI
- https://doi.org/10.21037/tcr-2025-922
- Primary Topic
- Lymphoma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00